Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer

NCT00019006 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00019006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00019006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1995
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung cancer, limited stage small cell lung cancer, recurrent colon cancer, recurrent pancreatic cancer, recurrent rectal cancer, stage i pancreatic cancer, stage ii non-small cell lung cancer, stage ii pancreatic cancer, stage iii colon cancer, stage iii non-small cell lung cancer, stage iii pancreatic cancer, stage iii rectal cancer, stage iva pancreatic cancer, stage ivb pancreatic cancer